Document is current
Any future updates will be listed below
-
Authors
Jaun, Fabienne https://orcid.org/0000-0002-1229-2181
Boesing, Maria
Lüthi-Corridori, Giorgia
Abig, Kristin
Makhdoomi, Anja
Bloch, Nando
Lins, Christina
Raess, Andrea
Grillmayr, Victoria
Haas, Philippe
Schuetz, Philipp
Gabutti, Luca
Muser, Jürgen
Leuppi-Taegtmeyer, Anne B.
Giezendanner, Stéphanie
Brändle, Michael
Leuppi, Jörg D.
-
Funding
Funding for this research was provided by:
SWICA (n.a.)
Stiftung für wissenschaftliche Forschung (n.a.)
Spendenstiftung Bank Vontobel (n.a.)
Gebro Pharma AG
- License Information
-
More Information
Article History
Received: 19 November 2020
Accepted: 10 January 2022
First Online: 4 February 2022
Declarations
:
: Attached to this document is the statement of the Swiss ethics committee (BASEC No: 2020-01401). In this case, several local ethical committees are involved.EKNZ (ethical committee of north-western and central Switzerland) is the lead ethics committee in this trial. Full ethical approval was granted on September 23, 2020.EKOS (ethical committee of eastern Switzerland): The obligation was fulfilled, and we are awaiting the answer and the full approval.CEC TI (ethical committee of Ticino): We are in the process of translating the documents into Italian for submission.Written informed consent will be obtained from all study participants.
: No personal data and/or video of any patient is used in this manuscript; therefore, a consent for publication is not needed.
: The authors declare that they have no competing interests.
